OPTIMIZERX CORP (OPRX)
US68401U2042 - Common Stock
We assign a fundamental rating of 4 out of 10 to OPRX. OPRX was compared to 37 industry peers in the Health Care Technology industry. While OPRX seems to be doing ok healthwise, there are quite some concerns on its profitability. OPRX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
OPRX had positive earnings in the past year.
In the past year OPRX has reported a negative cash flow from operations.
OPRX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OPRX reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of OPRX (-14.63%) is better than 66.67% of its industry peers.
The Return On Equity of OPRX (-21.12%) is better than 69.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.63% | ||
| ROE | -21.12% | ||
| ROIC | N/A |
ROA(3y)-5.93%
ROA(5y)-5.4%
ROE(3y)-7.55%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OPRX has a Gross Margin (62.60%) which is in line with its industry peers.
In the last couple of years the Gross Margin of OPRX has remained more or less at the same level.
OPRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.6% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y0.83%
2. Health
2.1 Basic Checks
OPRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
OPRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OPRX has more shares outstanding
The debt/assets ratio for OPRX is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.89, we must say that OPRX is in the distress zone and has some risk of bankruptcy.
OPRX has a Altman-Z score of 0.89. This is comparable to the rest of the industry: OPRX outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that OPRX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.29, OPRX is in line with its industry, outperforming 47.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.89 |
ROIC/WACCN/A
WACC10.92%
2.3 Liquidity
A Current Ratio of 3.23 indicates that OPRX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.23, OPRX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
OPRX has a Quick Ratio of 3.23. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
OPRX's Quick ratio of 3.23 is fine compared to the rest of the industry. OPRX outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.23 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.83% over the past year.
Measured over the past years, OPRX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.58% on average per year.
OPRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.41%.
The Revenue has been growing by 27.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20.83%
EPS 3Y9.58%
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)40.41%
Revenue growth 3Y18.2%
Revenue growth 5Y27.52%
Sales Q2Q%30.48%
3.2 Future
OPRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.74% yearly.
Based on estimates for the next years, OPRX will show a quite strong growth in Revenue. The Revenue will grow by 13.41% on average per year.
EPS Next Y15.41%
EPS Next 2Y18.27%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year26.75%
Revenue Next 2Y19.13%
Revenue Next 3Y13.41%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.93, which indicates a correct valuation of OPRX.
Based on the Price/Earnings ratio, OPRX is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of OPRX to the average of the S&P500 Index (27.20), we can say OPRX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.04, the valuation of OPRX can be described as correct.
OPRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. OPRX is cheaper than 88.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OPRX to the average of the S&P500 Index (23.73), we can say OPRX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.93 | ||
| Fwd PE | 14.04 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as OPRX's earnings are expected to grow with 15.74% in the coming years.
PEG (NY)1.1
PEG (5Y)N/A
EPS Next 2Y18.27%
EPS Next 3Y15.74%
5. Dividend
5.1 Amount
OPRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OPTIMIZERX CORP
NASDAQ:OPRX (12/20/2024, 8:00:02 PM)
Premarket: 4.85 -0.06 (-1.22%)4.91
+0.16 (+3.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners74.4%
Inst Owner Change-12.92%
Ins Owners12.8%
Ins Owner Change0.88%
Market Cap90.44M
Analysts82.86
Price Target10.49 (113.65%)
Short Float %6.29%
Short Ratio3.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)110.68%
Min EPS beat(2)90.65%
Max EPS beat(2)130.72%
EPS beat(4)3
Avg EPS beat(4)53.92%
Min EPS beat(4)-21.08%
Max EPS beat(4)130.72%
EPS beat(8)6
Avg EPS beat(8)64.26%
EPS beat(12)9
Avg EPS beat(12)47.25%
EPS beat(16)12
Avg EPS beat(16)52.43%
Revenue beat(2)0
Avg Revenue beat(2)-12.55%
Min Revenue beat(2)-16.43%
Max Revenue beat(2)-8.68%
Revenue beat(4)2
Avg Revenue beat(4)-4.13%
Min Revenue beat(4)-16.43%
Max Revenue beat(4)6.46%
Revenue beat(8)4
Avg Revenue beat(8)-3.46%
Revenue beat(12)4
Avg Revenue beat(12)-4.18%
Revenue beat(16)8
Avg Revenue beat(16)-2.01%
PT rev (1m)0%
PT rev (3m)-30.97%
EPS NQ rev (1m)-17.45%
EPS NQ rev (3m)-32.39%
EPS NY rev (1m)-20.17%
EPS NY rev (3m)-20.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.48%
Revenue NY rev (1m)-11.27%
Revenue NY rev (3m)-11.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.93 | ||
| Fwd PE | 14.04 | ||
| P/S | 1.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)0.29
EY5.91%
EPS(NY)0.35
Fwd EY7.12%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS4.79
BVpS6.21
TBVpS-0.16
PEG (NY)1.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.63% | ||
| ROE | -21.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.6% | ||
| FCFM | N/A |
ROA(3y)-5.93%
ROA(5y)-5.4%
ROE(3y)-7.55%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.52%
GM growth 5Y0.83%
F-Score3
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 10.59% | ||
| Cap/Sales | 0.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.23 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | 0.89 |
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)23.84%
Cap/Depr(5y)42.47%
Cap/Sales(3y)0.78%
Cap/Sales(5y)1.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.83%
EPS 3Y9.58%
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.41%
EPS Next 2Y18.27%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)40.41%
Revenue growth 3Y18.2%
Revenue growth 5Y27.52%
Sales Q2Q%30.48%
Revenue Next Year26.75%
Revenue Next 2Y19.13%
Revenue Next 3Y13.41%
Revenue Next 5YN/A
EBIT growth 1Y27.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.23%
EBIT Next 3Y56.83%
EBIT Next 5YN/A
FCF growth 1Y-118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.05%
OCF growth 3YN/A
OCF growth 5YN/A